Jonathan Noble

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Glenwood Goss, Chris J. O’Callaghan, Ian Lorimer et al. · Journal of Clinical Oncology · 2013 · 359 citations · Full text

Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21

Andrea Bezjak, Dongsheng Tu, Lesley Seymour et al. · Journal of Clinical Oncology · 2006 · 294 citations · Full text

Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study

Glenwood Goss, Andrew Arnold, Frances A. Shepherd et al. · Journal of Clinical Oncology · 2009 · 243 citations

Advanced Nsclc, Medicine, Phase Iii +12

Phase II Clinical Trial Results Involving Treatment with Low-Dose Daily Oral Cyclophosphamide, Weekly Vinblastine, and Rofecoxib in Patients with Advanced Solid Tumors

Scott D. Young, Mark Whissell, Jonathan Noble et al. · Clinical Cancer Research · 2006 · 110 citations · Full text

Splicing of SV40 early pre-mRNA to large T and small t mRNAs utilizes different patterns of lariat branch sites

Jonathan Noble, Zhen‐Qiang Pan, Carol Prives et al. · Cell · 1987 · 94 citations

Engineering, Genetics, Sv40 Early Pre-mrna +12